KIST Europe

I. 2022년 독일 연구 혁신 및 기술역량 평가 (EFI 연구혁신 전문위원회)

* 연방정부에 대한 EFI 권고: 2022년 주요 테마

○ 핵심기술 및 기술주권 확보

○ 지속 가능성을 위한 개인 모빌리티

○  독일 의료 시스템 디지털화 촉진

II. 프라운호퍼 연구 동향

1. 폐의 면역 반응 검사

2. 인프라-바우 4.0을 통한 건설의 효율성 개선

3. 메탄올에서 얻은 수소: 최적화된 개질기

III. 유럽연합 동향

1. 클린 수소기술(clean hydrogen technologies) 과제 공시

Call for proposals: Europe is investing €300.5 million in clean hydrogen technologies

https://www.clean-hydrogen.europa.eu/media/news/call-proposals-europe-investing-eu3005-million-clean-hydrogen-technologies-2022-02-28_en

2. 유럽연합집행위 국방 연구혁신 개발 로드맵

(Roadmap on critical technologies for security and defence) 

https://ec.europa.eu/info/sites/default/files/com_2022_61_1_en_act_roadmap_security_and_defence.pdf

3. 유럽 배터리 연합(European Battery Alliance) 6차회담

https://ec.europa.eu/commission/presscorner/detail/en/IP_22_1256

○ 유럽 배터리 연합(European Battery Alliance)의 제6차 고위급 회의에서 유럽의 배터리

    밸류체인 발전 과정을 협의, 2022년 작업 우선 순위를 제시

- 배터리 전문 인력 교육을 위해 유럽 배터리 아카데미(European Battery Academy) 출범

   2025년까지 약 80만명, 매년 16만명 교육 혹은 재교육 시행 예정,(일자리 3-4백만 창출)

https://www.eba250.com/eba-academy/about-eba-academy/?cn-reloaded=1&cn-reloaded=1

4. 유럽연합 러시아와 연구 혁신 관련 협력 중단

https://ec.europa.eu/commission/presscorner/detail/en/IP_22_1544

○ 유럽 집행위는 러시아의 우크라이나 침공이후 연구, 과학기술 및 혁신 분야에서의 러시아 기관들과의 협력을 중단하기로 결정함(3월 4일),

- 새로운 계약을 체결하지 않으며, 기존 계약에 대해서도 러시아 기관에 대한 지급을 중단함

5. 유럽 JRC 희귀질환 등록을 위한 새로운 플랫폼

https://joint-research-centre.ec.europa.eu/jrc-news/new-user-friendly-tool-european-platform-rare-disease-registration-2022-02-28_en

○ 공동연구센터(JRC)는 유럽 전역의 희귀 질환 레지스트리 데이터 통합을 용이하게 하는 도구인

    새로운 버전의 Central Metadata Repository를 출시

- 3천만명의 유럽인들이 6000개 이상의 희귀질환에 노출되고 있지만 수백개의 레지스트리에

  분산되어 어려움이 있었기에 중앙 메타 데이터 통합을 통해 연구 데이터 사용이 용이하게 됨